CCL20 and COVID-19: The analyses of these 7 gene expression levels between different clinical features suggested that BTK, SDK1, CCL20, LDHA, and ZIC5 may serve as effective biomarkers for screening and characterizing patients with LUAD/COVID-19 at different stages.